Who Just RaisedCambridge, MA · Health Care · Form D filed Sep 21, 2026
Typewriter Therapeutics, Inc. raised $56.3M
Typewriter Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts. In a Form D filed with the SEC on September 21, 2026, it reported raising $56,299,999 from 6 investors as part of an offering of up to $56,299,999. The first sale in the offering took place on January 8, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
$56.3M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 21, 2026 | $56.3M | $56.3M | 6 |
Lead score
39 out of 100
filed recently first raise ever budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $56,299,999
- Offering size
- $56,299,999
- Investors so far
- 6
- First sale
- January 8, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Cambridge, Massachusetts
- Incorporated
- Delaware, 2022
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $56,299,999 | $56,299,999 | 6 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 21, 2026 · Health Care funding in Massachusetts · September 2026 funding report
Similar raises
Cambridge Heavy Industries Inc.
Cambridge, MA · filed Oct 7First Form DStill raising
Way Biosolutions, Inc.
Cambridge, MA · filed Sep 25First Form D
SurgiBox Inc.
Cambridge, MA · filed Sep 174th Form D since 2022Still raising
Mantel Capture, Inc.
Cambridge, MA · filed Aug 244th Form D since 2022Still raising
Axelyf, Inc.
Chestnut Hill, MA · filed Oct 132nd Form D since 2025
Soterya, Inc.
Boston, MA · filed Oct 13First Form DStill raising
Bioventrix, Inc.
Mansfield, MA · filed Oct 8
OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…
26th Form D since 2009Still raising
Revbio, Inc.
Lowell, MA · filed Oct 2
TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.
4th Form D since 2019